• Main page
• About the journal
• Editorial board
• Subscription
• Information for contributors
• Editorial and Peer Review
• Issues archive
• Authors
• Articles
  • By alphabet
  • By category
• Blogs and comments

The journal is included into The list of leading scientific periodicals.

The journal is included into VINITI database and is registered in Electronic scientific library.

The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.

EBSCO

https://doi.org/10.14300/mnnc.2020.15143

Role of type IV collagen in the development of diabetic nephropathy in patients with diabetes mellitus

[Reviews]
Angelina Kalmykova; Alfiya Emilevna Abdullina;

Diabetic nephropathy (DN) is the most frequent and serious complication of type 1 diabetes mellitus, occupying one of the leading places in the structure of the causes of chronic renal failure. The search for new sensitive preclinical markers of this disease is urgent. The review discusses the known indicators of diabetic kidney damage, as well as the role of urinary excretion of type IV collagen as an early non-invasive marker of diabetic nephropathy.

Download

References:
1. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels: IDF, 2017.
2. Inroduction: Standarts of Medical Care in Diabetes – 2018. Diabetes Care. 2018;41(Suppl. 1):S1-S2. https://doi.org/10.2337/dc18-Sint01
3. Dedov I. I., Shestakova M. V. Sakharny diabet tipa 1: realii i perspektivy. M.: «Meditsinskoye informatsionnoye agentstvo», 2016. (In Russ.).
4. Dedov I. I., Shestakova M. V., Vikulova O. K. Epidemiologiya sakharnogo diabeta v Rossyskoy federatsii: kliniko-statistichesky analiz po dannym Federalnogo registra sakharnogo diabeta. Sakharny diabet. – Diabetes. 2017;20(1):13-41. (In Russ.). https://doi.org/10.14341/DM8664
5. Dedov I. I., Shestakova M. V., Peterkova V. A., Vikulova O. K., Zheleznyakova A. V. [et al.]. Sakharny diabet u detey i podrostkov podannym federalnogo registra RF: dinamika osnovnyсh epidemiologicheskikh kharakteristik za 2013–2016 gg. Sakharny diabet. – Diabetes. 2017;20(6):392-402. (In Russ.). https://doi.org/10.14341/DM9460
6. Mukhina Yu. G., Osmanov I. M., Dlin V. V., Belmer S. V., Chugunova O. L. Nefrologiya detskogo vozrasta. Izdaniye vtoroye, ispravlennoye i dopolnennoye. M: «ID Medpraktika-M», 2010. (In Russ.).
7. Uwaezuoke S. N., Chikani U. N., Mbanefo N. R. Diabetic Nephropathy in Childhood: Predictive Tools and Preventive Strategies, Advances in Nephropathy. Thomas Rath. Intech Open, 2018. https://doi.org/10.5772/intechopen.79331
8. Macisaac R. J., Ekinci E. I., Jerums G. Markers of and risk factors for the development and progression of diabetic kidney disease. Am. J. Kidney Dis. 2014;63(2):39-62. https://doi.org/10.1053/j.ajkd.2013.10.048
9. Ninomiya T., Perkovic V., de Galan B.E., Zoungas S., Pillai A. [et al.]. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J. Am. Soc. Nephrol. 2009;20:1813--1821. https://doi.org/10.1681/ASN.2008121270
10. World Health Organization, Global Status Report on Noncommunicable Diseases 2010, World Health Organization, Geneva, Switzerland, 2008.
11. Shestakova M. V. Saharnyj diabet i hronicheskaya bolezn’ pochek: vozmozhnosti prognozirovaniya, rannej diagnostiki i nefroprotekcii v XXI veke. Terapevticheskij arhiv. – Therapeutic archive. 2016;(88)6:84-88. (In Russ.). https://doi.org/10.17116/terarkh201688684-88
12. Collins A. J., Foley R. N., Chavers B., Gilbertson D., Herzog C. [et al.]. United States Renal Data System 2011 Annual Data Report: atlas of chronic kidney disease & endstage renal disease in the United States. Am. J. Kidney Dis. 2012;59(Suppl.1):A7,e1–e420. https://doi.org/10.1053/j.ajkd.2011.11.015
13. Shumilov P. V., Petrosyan E. K., Chugunova O. L. Detskaya nefrologiya. M: «MEDpress-inform», 2018. (In Russ.).
14. Kim S. S., Kim J. H., Kim I. J. Current Challenges in Diabetic Nephropathy: Early Diagnosis and Ways to Improve Outcomes. Endocrinol. Metab. 2016;31(2):245-253. https://doi.org/10.3803/EnM.2016.31.2.245
15. Tuttle K. R., Bakris G. L., Bilous R. W., Chiang J. L., de Boer I. H. [et al.]. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014;37:2864-2883.https://doi.org/10.2337/dc14-1296
16. Kiselnikova O. V., Mozzhukhina L. I., Spivak E. M. Kliniko-funktsionalnaya kharakteristika diabeticheskoy nefropatii u detey. Meditsinskiy sovet. – Medical advice. 2018;11:132-135. (In Russ.). https://doi.org/10.21518/2079-701X-2018-11-132-135
17. Dedov I. I., Shestakova M. V., Alexandrov A. A., Galstyan G. R., Grigoryan O. R. [et al.]. Standards of specialized diabetes care. Edited by Dedov I. I., Shestakova M. V. Sakharny diabet. – Diabetes. 2013;(1):1-120. (In Russ.). https://doi.org/10.14341/DM20131S1-121
18. American Diabetes Association. Standards of medical care in diabetes – 2014. Diabetes Care. 2014;37(Suppl.1):14-80. https://doi.org/10.2337/dc14-S014
19. Currie G., McKay G., Delles C. Biomarkers in diabetic nephropathy: present and future. World J. Diabetes. 2014;5:763-776. https://doi.org/10.4239/wjd.v5.i6.763
20. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Мanagement of Chronic Kidney Disease. Kidney Int. Suppl. 2013;3(1):1-150. https://doi.org/10.1053/j.ajkd.2014.01.416
21. Uwaezuoke S. N. The role of novel biomarkers in predicting diabetic nephropathy: a review. Int. J. Nephrol. Renovasc. Dis. 2017;10:221-231. https://doi.org/10.2147/IJNRD.S143186
22. Matheson A., Willcox M. D. P., Flanagan J., Walsh B. J. Urinary biomarkers involved in type 2 diabetes: A review. Diabet. Metab. Res. Rev. 2010;26:150-171. https://doi.org/10.1002/dmrr.1068
23. Perkins B. A., Ficociello L. H., Roshan B., Warram J. H.,Krolewski A. S. In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int. 2010;77:57-64. https://doi.org/10.1038/ki.2009.399
24. Macisaac R. J., Jerums G. Diabetic kidney disease with and without albuminuria. Curr. Opin. Nephrol. Hypertens. 2011;20:246-257. https://doi.org/10.1097/MNH.0b013e3283456546
25. An J. H., Cho Y. M., Yu H. G., Jang H. C., Park K. S. [et al.]. The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complication. J. Korean Med. Sci. 2009;24:75-81. https://doi.org/10.3346/jkms.2009.24.S1.S75
26. Zachwieja J., Soltysiak J., Fichna P., Lipkowska K., Stankiewicz W. [et al.]. Normal-range albuminuria does not exclude nephropathy in diabetic children. Pediatr. Nephrol. 2010;25:1445-1451. https://doi.org/10.1007/s00467-010-1443-z
27. Camargo E. G., Soares A. A., Detanico A. B. The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is less accurate in patients with type 2 diabetes when compared with healthy individuals. Diabet. Med. 2011;28:90-95. http://doi.org/10.1111/j.1464-5491.2010.03161
28. Sharma K. The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney Int. 2009;76:145-148. https://doi.org/10.1038/ki.2009.137
29. Glassock R. J. Is the presence of microalbuminuria a relevant marker of kidney disease? Curr. Hypertens Rep. 2010;12(5):364-368. https://doi.org/10.1007/s11906-010-0133-3
30. Carole G. Campion, Oraly Sanchez-Ferras, Sri N. Batchu. Potential Role of Serum and Urinary Biomarkers in Diagnosis and Prognosis of Diabetic Nephropathy. Can. J. Kidney Health. Dis. 2017;4:2054358117705371. https://doi.org/10.1177/2054358117705371
31. Pertseva N. O., Chub D. I. Kliniko-laboratornyye pokazateli ranney diagnostiki progressirovaniya diabeticheskoy nefropatii u bolnykh sakharnym diabetom 1 tipa. Urologiya. – Urology. 2018;22(1-84):54-61. (In Russ.). https://doi.org/10.26641/2307-5279.22.1.2018.128148
32. Lebedeva N. O., Vikulova O. K. Markery doklinicheskoy diagnostiki diabeticheskoy nefropatii u patsiyentovs sakharnym diabetom 1 tipa. Sakharny diabet. – Diabetes. 2012;(2):38-45. (In Russ.).
33. Dedov I. I., Shestakova M. V. Sakharnyy diabet: ostryye i khronicheskiye oslozhneniya. M., 2016. (In Russ.).
34. Aguiar P., Azevedo O., Pinto R., Marino J., Baker R. [et al.]. New biomarkers defining a novel early stage of Fabry nephropathy: A diagnostic test study. Mol. Gen. Metab. 2017;121(2):162-169. https://doi.org/10.1016/j.ymgme.2017.05.007
35. Cosgrove D., Liu S. Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. Matrix Biol. 2017;(57-58):45-54. https://doi.org/10.1016/j.matbio.2016.08.005
36. Pedchenko V., Kitching A. R., Hudson B. G. Goodpasture’s autoimmune disease A collagen IV disorder. Matrix Biol. 2018;(71-72):240-249. https://doi.org/10.1016/j.matbio.2018.05.004
37. Fiseha T. Urinary biomarkers for early diabetic nephropathy in type 2 diabetic patients. Biomark Res. 2015;3:16. https://doi.org/10.1186/s40364-015-0042-3
38. Ming S., Qi Z., Wang L., Zhu K. Urinary type IV collagen: a specific indicator of incipient diabetic nephropathy. Chin. Med. J. 2002;115(3):389-394.
39. Samotruyeva M. A., Sergaliyeva M. U. Sakharny diabet: osobennosti eksperimentalnogo modelirovaniya. Astra khansky meditsinsky zhurnal. – Astrakhan Medical Journal. 2019;14(3):45-57. (In Russ.). https://doi.org/10.17021/2019.14.3.45.57
40. Klimontov V. V., Yeremenko N. V., Myakina N. E., Fazullina O. N. Tsistatin S i kollagen IV tipa v diagnostike khronicheskoy bolezni pochek u bolnykh sakharnym diabetom 2 tipa. Sakharny diabet. – Diabetes. 2015;(1):87-93. (In Russ.). https://doi.org/10.14341/DM2015187-93
41. Araki S., Haneda M., Koya D., Isshiki K., Kume S. [et al.]. Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria. Diabetes Care. 2010;33(8):1805-1810. https://doi.org/10.2337/dc10-0199
42. Inomat S., Haneda M., Moriya T., Katayama S., Iwamoto Y. [et al.]. Revised criteria for the early diagnosis of diabetic nephropathy. J. Jap. Diabet. Soc. 2005;48(10):757-759.
43. Cheng Wang, Cui Cui Li, Wen Yu Gong, Tanqi Lou. New urinary biomarkers for diabetic kidney disease. Biomarker Res. 2013;1:9. https://doi.org/10.1186/2050-7771-1-9
44. Cawood T. J., Bashir M., Brady J., Murray B., Murray P. T., O’Shea D. Urinary collagen IV and πGST: potential biomarkers for detecting localized kidney injury in diabetes-a pilot study. Am. J. Nephrol. 2010;32(3):219-225.
45. Ogawa S., Matsushima M., Okamura M., Senda M., Sakamoto T. [et al.]. Urinary type IV collagen excretion predicts an increased urinary albumin-to-creatinine ratio in normoalbuminuric patients with diabetes. J. Diabetes Mellit. 2012;2:413-426. https://doi.org/10.4236/jdm.2012.24065
46. Mahendran K. B., Bhaskar M. V., Santha K., Inmozhi R., Perumal K. K. Plasma and Urinary Type IV Collagen Levels for Early Detection of Nephropathy in Type 2 Diabetes Mellitus Patients. Int. J. Health Sci. (Qassim). 2016;10(4):492-498. https://doi.org/10.12816/0048890
47. Awwad D., Al-Sabbagh A., Al-Quobaili F. Urinary Type IV Collagen Levels in Syrian Type II Diabetic Nephropathy Patients. Int. J. Pharm. Sci. Rev. Res. 2013;22(2):103-108.
48. Kotajima N., Kimura T., Kanda T., Obata K., Kuwabara A. [et al.]. Type IV collagen as an early marker for diabetic nephropathy in non- insulin-dependent diabetes mellitus. J. Diabet. Compl. 2000;14:13-17.
49. Morita M., Uchigata Y., Hanai K., Ogawa Y., Iwamoto Y. Association of urinary type IV collagen with GFR decline in young patients with type 1 diabetes. Am. J. Kidney Dis. 2011;58(6):915-920. https://doi.org/10.1053/j.ajkd.2011.04.019
50. Katavetin P., Katavetin P., Susantitaphong P., Townamchai N., Tiranathanagul K. [et al.]. Urinary type IV collagen excretion predicts subsequent declining renal function in type 2 diabetic patients with proteinuria. Diabet. Res. Clin. Pract. 2010;89(2):33-35. https://doi.org/10.1016/j.diabres.2010.05.007
51. Furumatsu Y., Nagasawa Y., Shoji T., Yamamoto R., Iio K. [et al.]. Urinary type IV collagen in nondiabetic kidney disease. Nephron. Clin. Pract. 2011;117(2):160-166. https://doi.org/10.1159/000319794
52. Kishi F., Nagai K., Takamatsu N., Tominaga T., Tamaki M. [et al.]. Urinary type IV collagen excretion is involved in the decline in estimated glomerular filtration rate in the Japanese general population without diabetes: A 5-year observational study. PLoS One. 2018;13(4):195-523. https://doi.org/10.1371/journal.pone.0195523
53. Nicoloff G., Baydanoff S., Stanimirova N., Petrova C., Christova P. Detection of serum collagen type IV in children with type 1 (insulin-dependent) diabetes mellitus--a longitudinal study. Pediatr. Diabetes. 2001;2(4):184-190. https://doi.org/10.1016/s1537-1891(02)00214-8
54. Adler S. G., Feld S., Striker L., Striker G., LaPage J. [et al.]. Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease. Kidney Int. 2000;57(5):2084-2092. https://doi.org/10.1046/j.1523-755.2000.00058.x
55. Bondar I. A., Klimontov V. V., Parfentyeva Ye. M., Romanov V. V., Nadeyev A. P. Mochevaya ekskretsiya kollagena IV tipa – ranny marker fibrozirovaniya pochek pri sakharnom diabete. Sakharny diabet. – Diabetes. 2011;14(4):29-31. (In Russ.).
56. Miner J. H. Type IV collagen and diabetic kidney disease. Nat. Rev. Nephrol. 2020;16(1):3-4. https://doi.org/10.1038/s41581-019-0229-1
57. Salem R. M., Todd J. N., Sandholm N., Cole J. B., Chen W. M. [et al.]. Florez Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen. J. Am. Soc. Nephrol. 2019;30(10):2000-2016. https://doi.org/10.1101/499616

Keywords: children, diabetes mellitus type 1, diabetic nephropathy, microalbuminuria, glomerular filtration rate, type IV collagen